Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Episode 28: Targeting VHL Syndrome Renal Cancer with a HIF Inhibitor - A Game Changer

    Episode 28: Targeting VHL Syndrome Renal Cancer with a HIF Inhibitor - A Game Changer

    FromThe Uromigos

    Start listeningView podcast show

    Episode 28: Targeting VHL Syndrome Renal Cancer with a HIF Inhibitor - A Game Changer

    FromThe Uromigos

    ratings:
    Length:
    14 minutes
    Released:
    May 29, 2020
    Format:
    Podcast episode

    Description

    Eric Jonasch discusses his ASCO presentation, which shows significant activity of HIF targeting in renal cancer patients with VHL syndrome. 
    Released:
    May 29, 2020
    Format:
    Podcast episode

    Titles in the series (100)

    Broadcasting the latest developments in GU cancer